Literature DB >> 17498560

The A4396G polymorphism in interferon regulatory factor 1 is frequently expressed in breast cancer cell lines.

Kerrie B Bouker1, Todd C Skaar, David S Harburger, Rebecca B Riggins, David R Fernandez, Alan Zwart, Robert Clarke.   

Abstract

Loss or mutation of known tumor suppressor genes accounts for a small proportion of all breast cancers. We have recently shown that interferon regulatory factor 1 (IRF1) is a putative tumor suppressor gene in breast cancer. We now report that the A4396G single nucleotide polymorphism in the IRF1 gene is more frequent in human breast cancer cell lines than in the general population (P = 0.01). Furthermore, A4396G is more frequently expressed in African American (black) than in European ancestry (white) subjects (n = 70 subjects; P < or = 0.001), leading to a significant difference in genotype distribution between these populations (P = 0.002).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17498560     DOI: 10.1016/j.cancergencyto.2006.12.008

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  8 in total

1.  Interferon regulatory factor 1 regulates PANoptosis to prevent colorectal cancer.

Authors:  Rajendra Karki; Bhesh Raj Sharma; Ein Lee; Balaji Banoth; R K Subbarao Malireddi; Parimal Samir; Shraddha Tuladhar; Harisankeerth Mummareddy; Amanda R Burton; Peter Vogel; Thirumala-Devi Kanneganti
Journal:  JCI Insight       Date:  2020-06-18

2.  Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells.

Authors:  Robert Clarke; Ayesha N Shajahan; Rebecca B Riggins; Younsook Cho; Anatasha Crawford; Jianhua Xuan; Yue Wang; Alan Zwart; Ruchi Nehra; Minetta C Liu
Journal:  J Steroid Biochem Mol Biol       Date:  2009-03       Impact factor: 4.292

3.  Frequent loss of heterozygosity at the interferon regulatory factor-1 gene locus in breast cancer.

Authors:  Luciane R Cavalli; Rebecca B Riggins; Antai Wang; Robert Clarke; Bassem R Haddad
Journal:  Breast Cancer Res Treat       Date:  2009-08-21       Impact factor: 4.872

4.  Potential Biomarker of L-type Amino Acid Transporter 1 in Breast Cancer Progression.

Authors:  Zhongxing Liang; Heidi T Cho; Larry Williams; Aizhi Zhu; Ke Liang; Ke Huang; Hui Wu; Chunsu Jiang; Samuel Hong; Ronald Crowe; Mark M Goodman; Hyunsuk Shim
Journal:  Nucl Med Mol Imaging       Date:  2010-11-24

5.  The Role of Interferon Regulatory Factor-1 (IRF1) in Overcoming Antiestrogen Resistance in the Treatment of Breast Cancer.

Authors:  J L Schwartz; A N Shajahan; R Clarke
Journal:  Int J Breast Cancer       Date:  2011-07-03

6.  Novel IRF-1 Mutations in a Small Cohort of Leukaemia Patients From Saudi Arabia

Authors:  Khaldoon Alsamman; Xiuli Zhang; Chittibabu Vatte; Mohammad Al Hamad; Omar S El-Masry; Amani Y Owaidah; Faisal Alzahrani; Yao Lin
Journal:  Asian Pac J Cancer Prev       Date:  2017-10-26

Review 7.  Interferon regulatory factor 1 inactivation in human cancer.

Authors:  Khaldoon Alsamman; Omar S El-Masry
Journal:  Biosci Rep       Date:  2018-05-08       Impact factor: 3.840

8.  Function and mechanism by which interferon regulatory factor-1 inhibits oncogenesis.

Authors:  Fei-Fei Chen; Guan Jiang; Kerui Xu; Jun-Nian Zheng
Journal:  Oncol Lett       Date:  2012-11-28       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.